![Ming De Xia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ming De Xia
Director Ejecutivo en Innolake Pharmaceuticals (Hangzhou) Co., Ltd. .
Perfil
Ming De Xia has founded Innolake Pharmaceuticals (Hangzhou) Co., Ltd.
in 2020 and currently holds the position of Chairman & Chief Executive Officer.
Cargos activos de Ming De Xia
Empresas | Cargo | Inicio |
---|---|---|
Innolake Pharmaceuticals (Hangzhou) Co., Ltd.
![]() Innolake Pharmaceuticals (Hangzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Innolake Pharmaceuticals (Hangzhou) Co., Ltd. is a company based in Hangzhou, China that engages in the development and commercialization of therapeutic drugs for tumors and immune system diseases. The Chinese company was founded in 2020 by Ru Lei Chen and Ming De Xia, with Ming De Xia serving as the CEO since 2020. | Director Ejecutivo | 01/12/2020 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Innolake Pharmaceuticals (Hangzhou) Co., Ltd.
![]() Innolake Pharmaceuticals (Hangzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Innolake Pharmaceuticals (Hangzhou) Co., Ltd. is a company based in Hangzhou, China that engages in the development and commercialization of therapeutic drugs for tumors and immune system diseases. The Chinese company was founded in 2020 by Ru Lei Chen and Ming De Xia, with Ming De Xia serving as the CEO since 2020. | Health Technology |
- Bolsa de valores
- Insiders
- Ming De Xia